The effects of etodolac, nimesulid and naproxen sodium on the frequency of sister chromatid exchange after enclused third molars surgery

Yonsei Medical Journal

Volumn 49, Issue 5, 2008, Pages 742-747

  Köseoǧlu, Banu Gürkan ^a   Öztürk, Şükrü ^b   Koçak, Hülya ^a   Palanduz, Şükrü ^b   Çefle, Kivanç ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Genotoxicity; Non steroidal anti inflammatory drugs; Oral surgery; Sister chromatid exchange

Indexed keywords

ETODOLAC; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; DENTAL SURGERY; DRUG EFFICACY; ENVIRONMENTAL FACTOR; FEMALE; GENOTOXICITY; HUMAN; MALE; MOLAR TOOTH; PERIPHERAL LYMPHOCYTE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SISTER CHROMATID EXCHANGE; SURGICAL TECHNIQUE; TREATMENT DURATION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ETODOLAC; FEMALE; HUMANS; MALE; MOLAR, THIRD; MUTAGENICITY TESTS; NAPROXEN; PROSPECTIVE STUDIES; SISTER CHROMATID EXCHANGE; SULFONAMIDES;

EID: 58149529362     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.5.742     Document Type: Article

References (28)

1. Roux L, Liang MH. Osteoarthritis. In: Rakel RE, Bope ET, editors. Conn's current therapy 2001. Philadelphia: WB Saunders Company; 2000. p.969-70.
2. Martindle, the extra pharmacopoeia, nonsteroidal anti-inflammatory drugs. In: Reynolds JEF, editor. 31st ed. London: The Pharmaceutical Press; 1996. p.72-5.
3. Balfour JA, Buckley MM. Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states. Drugs 1991;42:274-99.
4. USPDI Drug information for the health care professional. In: Thomson PDR, editor. 17th ed. Vol. 1. Massachusetts: 1997. p.379-94.
5. American Hospital formulary service drug information 2000. In: McEvoy GK, editor. Bethesda, MO: American Society Health-System Pharmacists; 2005. p.1854-60.
6. Scott R, Ellis E 3rd, Upton LG. Double-blind evaluation of etodolac (200 mg, 400 mg) compared with zomepirac (100 mg) and placebo on third molar extraction pain. Oral Surg Oral Med Oral Pathol 1986;62:638-42.
7. Giglio JA, Campbell RL. Comparison of etodolac, zomepirac, and placebo for relief of pain after oral surgery. J Oral Maxillofac Surg 1986;44:765-70.
8. Fusetti G, Magni E, Armandola MC. Tolerability of nimesulide. Epidemiological data. Drugs 1993;46 Suppl 1:277-80.
9. Lee SH, Norppa H. Effects of indomethacin and arachidonic acid on sister chromatid exchange induction by styrene and styrene-7,8-oxide. Mutat Res 1995;348:175-81.
10. Kullich W, Klein G. Investigations of the influence of nonsteroidal antirheumatic drugs on the rates of sister-chromatid exchange. Mutat Res 1986;174:131-4.
11. Philipose B, Singh R, Khan KA, Giri AK. Comparative mutagenic and genotoxic effects of three propionic acid derivatives ibuprofen, ketoprofen and naproxen. Mutat Res 1997;393:123-31.
12. Özkul Y, Frenmemişoǧlu A, Ekecik A, Saatci C, Özdamar S, Demirtaş H. Do non-steroidal anti-inflammatory drugs induce sister chromatid exchanges in T lymphocytes? J Int Med Res 1996;24:84-7.
13. Sailer HF, Pajarola GF. Oral surgery for the general dentist. New York: Georg Thieme Verlag; 1999. p.80.
14. Latt SA. Sister chromatid exchanges, indices of human chromosome damage and repair: detection by fluorescence and induction by mitomycine. Proc Natl Acad Sci U S A 1974;71:3162-6.
15. Carrano AV, Thompson LH, Lindl PA, Minkler JL. Sister chromatid exchange as an indicator for mutagenesis. Nature 1978;271:551-3.
16. De Ferrari M, Artuso M, Bonassi S, Bonatti S, Cavalieri Z, Pescatore D, et al. Cytogenetic biomonitoring of an Italian population exposed to pesticides: chromosome aberration and sister-chromatid exchange analysis in peripheral blood lymphocytes. Mutat Res 1991;260:105-13.
17. Moorhead PS, Nowell PC, Mellman WJ, Battips DM, Hungerford DA. Chromosome preparations of leukocytes cultured from human peripheral blood. Exp Cell Res 1960;20:613-6.
18. Perry P, Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature 1974;251; 156-8.
19. Perera FP, Whyatt RM. Biomarkers and molecular epidemiology in mutation/ cancer research. Mutat Res 1994;313:117-29.
20. Dean BJ, Danford N. Assays for the detection of chemically induced chromosome damage in cultured mammalian cells. In: Venitt S, Parry JM, editors. Mutagenicity testing: A practical approach. USA: Oxford University Press; 1984. p.187-232.
21. Nakanishi Y, Schneider EL. In vivo sister-chromatid exchange: a sensitive measure of DNA damage. Mutat Res 1979;60:329-37.
22. Gebhart E. Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing. Hum Genet 1981;58:235-54.
23. Carrano AV, Moore DH. The rationale methodology for quantifying sister-chromatid exchanges in humans. In: Heddle JA, editor. New horizons in genetic toxicology, New York: Academic Press; 1982. p.267-304.
24. Rowland RE, Harding KM. Increased sister chromatid exchange in the peripheral blood lymphocytes of young women who smoke cigarettes. Hereditas 1999; 131:143-6.
25. Barale R, Chelotti L, Davini T, Del Ry S, Andreassi MG, Ballardin M. Sister chromatid exchange and micronucleus frequency in human lymphocytes of 1,650 subjects in an Italian population: II. Contribution of sex, age and lifestyle. Environ Mol Mutagen 1998;31:228-42.
26. Carbonell E, Peris F, Xamena N, Creus A, Marcos R. SCE analysis in human lymphocytes of a Spanish control population. Mutat Res 1995;335:35-46.
27. Öztürk P, Palanduz Ş, Aktan M, Çefle K, Serakinci N, Perkçelen Y. Sister chromatid exchange frequency in B-cells stimulated by TPA in chronic lymphocytic leukemia. Cancer Genet Cytogenet 2000;123:49-51.
28. Palanduz Ş, Sever MŞ, Öztürk Ş, Taşçioǧlu C, Karan MA, Sönmez G, et al. Genotoxic potential of cyclosporine A in patients with renal transplantation. Cell Biol Toxicol 1999;15:13-7.